Intragastric Balloon Therapy

Abstract

Intragastric balloon therapy for the treatment of obesity has been utilized for many years internationally. In this chapter, we describe the different available options and what is currently FDA approved for use in the USA. Currently FDA balloons are Reshape, Orbera, Obalon, and Trans Pyloric Shuttle. Trans Pyloric Shuttle is included in this chapter because it is a space-occupying device in the stomach similar to the intragastric balloons. The studies for each of the different balloons are reviewed for adverse effects and outcomes. Intragastric Balloon therapy is approved for the treatment of obesity within the BMI range of 30–39.9. Intragastric balloons are effective in this population and this chapter details expected weight loss and side effects. Longer term studies will be necessary to adequately evaluate the success and efficacy of intragastric balloon therapy.